{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004941","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.118929+00:00","generated_at":"2026-05-28T02:50:55.239227+00:00","sec_items":["2.02","9.01","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CareDx reports preliminary Q4 revenue up 30% YoY to ~$85.5M; guides 2025 revenue $370M","bullets":["Q4 revenue expected $85M-$86M, up ~30% YoY; testing services revenue $62.5M-$63.5M, up 35%.","Full year 2024 revenue $332M-$333M; GAAP loss $58M-$60M; adjusted EBITDA gain $25M-$26M.","Testing services volume ~45,500 in Q4, up 14% YoY; sixth consecutive quarter of volume growth.","Cash, equivalents, and marketable securities ~$261M as of Dec 31, 2024, up $26M YoY.","2025 revenue guidance of $370M; targeting $500M revenue and 20% adjusted EBITDA by 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004941","json":"https://secwatch.observer/filing/0001193125-25-004941.json","markdown":"https://secwatch.observer/filing/0001193125-25-004941.md","text":"https://secwatch.observer/filing/0001193125-25-004941.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000119312525004941/0001193125-25-004941-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000119312525004941/d909876d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T02:50:55.239227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}